Macrogenics (MGNX) Tax Rate (2024 - 2025)
Macrogenics' (MGNX) quarterly Tax Rate came in at 5.39% in Q4 2025, up 1191.0% year-on-year from 0.42% in Q4 2024, and up 1955.88% on a QoQ basis from 0.29% in Q2 2025.
Macrogenics (MGNX) Tax Rate (2024 - 2025) Analysis & Trends
Macrogenics (MGNX) has 2 years of Tax Rate data on file, last reported at 5.39% in Q4 2025.
- On a quarterly basis, Tax Rate rose 1191.0% year-over-year to 5.39% in Q4 2025; TTM through Dec 2025 was 0.32%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.93%, up 236.0% from the prior year.
- Tax Rate for Q4 2025 stood at 5.39%, up from 0.29% in the prior quarter.
- Over the last five years, Tax Rate for MGNX reached as high as 5.39% in Q4 2025 and fell as low as 6.52% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Macrogenics | 230.64 Mn | 164.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.39 |
| Dec 31, 2025 | 5.39 |
| Dec 31, 2025 | 5.39 |
| Jun 30, 2025 | -0.29 |
| Jun 30, 2025 | -0.29 |
| Jun 30, 2025 | -0.29 |
| Dec 31, 2024 | -6.52 |
| Dec 31, 2024 | -6.52 |
| Dec 31, 2024 | -6.52 |